Clinical Trials Browser

Phase 1/2 × Autoimmune Diseases × Clear all

NCT06359041 2026-02-20

RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis

Phase 1/2 Active not recruiting

Autoimmune Diseases, Myasthenia Gravis

NCT07032129 2025-06-22

BAH2573

Phase 1/2 Recruiting

Autoimmune Diseases, Multiple Myeloma, Neoplasms, Plasma Cell

NCT03283826 2024-02-23

EMBOLD

Phase 1/2 Terminated

Autoimmune Diseases, Demyelinating Diseases, Inflammation, Multiple Sclerosis, Epstein-Barr Virus Infections, Multiple Sclerosis, Chronic Progressive